Loading...
•
Mar 31, 2022
Chemed Q1 2022 Earnings Report
Chemed's financial performance for Q1 2022 was reported, with revenue up slightly but mixed results across its segments.
Key Takeaways
Chemed Corporation reported a slight increase in revenue for Q1 2022, with overall revenue rising by 0.6% to $531 million. While Roto-Rooter saw a revenue increase, VITAS experienced a decline. GAAP EPS increased by 5.2% to $4.22, and adjusted EPS increased by 7.9% to $4.79.
Chemed's revenue increased by 0.6% to $531 million.
GAAP Diluted Earnings-per-Share (EPS) increased 5.2% to $4.22.
Adjusted Diluted EPS increased 7.9% to $4.79.
Roto-Rooter's revenue increased 9.4%, while VITAS' net patient revenue decreased by 5.3%.
Chemed
Chemed
Chemed Revenue by Segment
Revenue by Segment
VITAS Revenue
CapyFin.comRoto-Rooter Revenue
CapyFin.com Forward Guidance
Management anticipates providing updated 2022 earnings guidance as part of the June 30, 2022, earnings press release.
Revenue & Expenses
Visualization of income flow from segment revenue to net income